Clinical trial
A Pilot Trial of the Effect of Dietary and Exercise Intervention on Insulin Resistance and Metabolic Parameters in De Novo Renal Transplant Recipients on Prograf (Tacrolimus)
NCT00492661 is registered in ClinicalTrials.gov with Janssen-Cilag Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Trial of the Effect of Dietary and Exercise Intervention on Insulin Resistance and Metabolic Parameters in De Novo Renal Transplant Recipients on Prograf (Tacrolimus)
- Lead sponsor
- Janssen-Cilag Pty Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- June 30, 2010
- Enrollment
- 55 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantion, renal transplantion